These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28865358)

  • 61. Dual stimuli polysaccharide nanovesicles for conjugated and physically loaded doxorubicin delivery in breast cancer cells.
    Pramod PS; Shah R; Jayakannan M
    Nanoscale; 2015 Apr; 7(15):6636-52. PubMed ID: 25797322
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression profiles of p53, p21, bax and bcl-2 proteins in all-trans-retinoic acid treated primary and metastatic melanoma cells.
    Zhang H; Rosdahl I
    Int J Oncol; 2004 Aug; 25(2):303-8. PubMed ID: 15254726
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
    Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
    Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: a possible explanation for tumor preventive action of retinoids.
    Mrass P; Rendl M; Mildner M; Gruber F; Lengauer B; Ballaun C; Eckhart L; Tschachler E
    Cancer Res; 2004 Sep; 64(18):6542-8. PubMed ID: 15374966
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of all-trans retinoic acid on drug sensitivity and expression of survivin in LoVo cells.
    Wei HB; Hu BG; Han XY; Zheng ZH; Wei B; Huang JL
    Chin Med J (Engl); 2008 Feb; 121(4):331-5. PubMed ID: 18304466
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas.
    Sundaresan A; Claypool K; Mehta K; Lopez-Berestein G; Cabanillas F; Ford RJ
    Cell Growth Differ; 1997 Oct; 8(10):1071-82. PubMed ID: 9342185
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.
    Reinhardt A; Liu H; Ma Y; Zhou Y; Zang C; Habbel JP; Possinger K; Eucker J
    Anticancer Res; 2018 May; 38(5):2669-2682. PubMed ID: 29715087
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.
    Patel JB; Mehta J; Belosay A; Sabnis G; Khandelwal A; Brodie AM; Soprano DR; Njar VC
    Br J Cancer; 2007 Apr; 96(8):1204-15. PubMed ID: 17387344
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chondroitin sulfate-capped super-paramagnetic iron oxide nanoparticles as potential carriers of doxorubicin hydrochloride.
    Mallick N; Anwar M; Asfer M; Mehdi SH; Rizvi MMA; Panda AK; Talegaonkar S; Ahmad FJ
    Carbohydr Polym; 2016 Oct; 151():546-556. PubMed ID: 27474599
    [TBL] [Abstract][Full Text] [Related]  

  • 71. All-trans-retinoic acid-induced apoptosis in human medulloblastoma: activation of caspase-3/poly(ADP-ribose) polymerase 1 pathway.
    Gumireddy K; Sutton LN; Phillips PC; Reddy CD
    Clin Cancer Res; 2003 Sep; 9(11):4052-9. PubMed ID: 14519626
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Apoptosis in esophageal cancer cells induced by all-trans retinoic acid].
    Lu TY; Fan QX; Wang LX; Wang RL; Zhao PR; Lu SX
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):822-5. PubMed ID: 18396638
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Regulation of inflammatory response of macrophages and induction of regulatory T cells by using retinoic acid-loaded nanostructured lipid carrier.
    Zai K; Ishihara N; Oguchi H; Hirota M; Kishimura A; Mori T; Hase K; Katayama Y
    J Biomater Sci Polym Ed; 2019 Jan; 30(1):1-11. PubMed ID: 29943678
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Compound Nanoemulsion Combined with Differentiation/Cytotoxicity Drugs for Modulating Breast Cancer Stemness.
    Chu Y; Su B; Luo Y; Li C; Zhang Y; Liu P; Chen H; Serda M; Jiang C; Sun T
    Mol Pharm; 2023 Mar; 20(3):1591-1598. PubMed ID: 36715483
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition of Zymosan-Induced Inflammatory Factors Expression by ATRA Nanostructured Lipid Carriers.
    Zhou H; Zhang W; Gao X; Zhang H; Kong N
    J Ophthalmol; 2016; 2016():4952340. PubMed ID: 27340562
    [TBL] [Abstract][Full Text] [Related]  

  • 76. All-Trans Retinoic Acid Grafted Poly Beta-Amino Ester Nanoparticles: A Novel Anti-angiogenic Drug Delivery System.
    Karimi N; Mansouri K; Soleiman-Beigi M; Fattahi A
    Adv Pharm Bull; 2020 Jun; 10(2):221-232. PubMed ID: 32373490
    [No Abstract]   [Full Text] [Related]  

  • 77. Ultrastructural Changes and Antitumor Effects of Doxorubicin/Thymoquinone-Loaded CaCO
    Ibiyeye KM; Nordin N; Ajat M; Zuki ABZ
    Front Oncol; 2019; 9():599. PubMed ID: 31334120
    [No Abstract]   [Full Text] [Related]  

  • 78. SIRT1 as a potential key regulator for mediating apoptosis in oropharyngeal cancer using cyclophosphamide and all-trans retinoic acid.
    Haggagy MG; Ahmed LA; Sharaky M; Elhefnawi MM; Omran MM
    Sci Rep; 2024 Jan; 14(1):41. PubMed ID: 38167952
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Co-delivery of Dacarbazine and All-Trans Retinoic Acid (ATRA) Using Lipid Nanoformulations for Synergistic Antitumor Efficacy Against Malignant Melanoma.
    Li C; Han X
    Nanoscale Res Lett; 2020 May; 15(1):113. PubMed ID: 32430641
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ATRA and Genistein synergistically inhibit the metastatic potential of human lung adenocarcinoma cells.
    Cheng J; Qi J; Li XT; Zhou K; Xu JH; Zhou Y; Zhang GQ; Xu JP; Zhou RJ
    Int J Clin Exp Med; 2015; 8(3):4220-7. PubMed ID: 26064333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.